The SURMOUNT phase 3 trials evaluated tirzepatide versus placebo in people with obesity or overweight with at least 1 ...
6mon
Best Life on MSNTirzepatide Has Patients Losing 23% of Their Body WeightEli Lilly announced the latest results from the SURMOUNT-1 three-year study on the efficacy of tirzepatide in an Aug. 20 ...
The results from a sub-population of patients in Lilly's SURMOUNT-1 trial suggest that tirzepatide could provide an alternative that, at least in theory, could require less dramatic lifestyle changes.
When Lilly reported strong results from SURMOUNT-1 earlier this year, the drugmaker suggested it may be able to file for approval of tirzepatide in obesity before the end of this year. That won't ...
A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...
Researchers found that women with hypertension who followed a very low-calorie ketogenic diet had lower systolic and diastolic blood pressure at 6 months than those who participated in intermittent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results